Erika Glusa

1.6k total citations
105 papers, 1.3k citations indexed

About

Erika Glusa is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Erika Glusa has authored 105 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 23 papers in Molecular Biology and 20 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Erika Glusa's work include Blood Coagulation and Thrombosis Mechanisms (34 papers), Nitric Oxide and Endothelin Effects (16 papers) and Protease and Inhibitor Mechanisms (12 papers). Erika Glusa is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (34 papers), Nitric Oxide and Endothelin Effects (16 papers) and Protease and Inhibitor Mechanisms (12 papers). Erika Glusa collaborates with scholars based in Germany, Czechia and Russia. Erika Glusa's co-authors include F Markwárdt, Heinz H. Pertz, Ellen Bretschneider, Karsten Schrör, M. Richter, S. M. Strukova, Annemieke Roos, T. N. Dugina, Roland Kaufmann and Jochen Lehmann and has published in prestigious journals such as Circulation, Journal of Molecular Biology and Biochemical and Biophysical Research Communications.

In The Last Decade

Erika Glusa

103 papers receiving 1.3k citations

Peers

Erika Glusa

HEMAT

CCM

PHYSI

CMN

Barrie Ashby United States

James D. Moffatt United Kingdom

Mirko Pinotti Italy

Mengzhou Xue Canada

A C Papp United States

Anthony Johns United States

Julia Winkler United States

Amy L. Firth United States

Patrick G. Quinn United States

R.G. Goldie Australia

Barrie Ashby United States

Erika Glusa

426 ×1.1

HEMAT

819 ×2.3

381 ×1.1

CCM

252 ×1.1

PHYSI

370 ×2.0

CMN

Citations per year, relative to Erika Glusa Erika Glusa (= 1×) peers Barrie Ashby

Countries citing papers authored by Erika Glusa

Since Specialization

Citations

This map shows the geographic impact of Erika Glusa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Glusa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Glusa more than expected).

Fields of papers citing papers by Erika Glusa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Glusa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Glusa. The network helps show where Erika Glusa may publish in the future.

Co-authorship network of co-authors of Erika Glusa

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Glusa. A scholar is included among the top collaborators of Erika Glusa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Glusa. Erika Glusa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Müller‐Schweinitzer, Else, et al.. (2008). Activated Rho/Rho kinase and modified calcium sensitivity in cryopreserved human saphenous veins. Cryobiology. 57(1). 37–45. 1 indexed citations

Abuo‐Rahma, Gamal El‐Din A., et al.. (2005). NO-donors, part 9 [1]: diazeniumdiolates inhibit human platelet aggregation and induce a transient vasodilatation of porcine pulmonary arteries in accordance with the NO-releasing rates. European Journal of Medicinal Chemistry. 40(3). 281–287. 6 indexed citations

Decker, Michael, Andreas König, Erika Glusa, & Jochen Lehmann. (2004). Synthesis and vasorelaxant properties of hybrid molecules out of NO-donors and the β-receptor blocking drug propranolol. Bioorganic & Medicinal Chemistry Letters. 14(19). 4995–4997. 11 indexed citations

Centurión, David, et al.. (2004). 5-HT7, but not 5-HT2B, receptors mediate hypotension in vagosympathectomized rats. European Journal of Pharmacology. 502(3). 239–242. 34 indexed citations

Glusa, Erika, et al.. (2003). The thrombin inhibitor argatroban does not influence the endothelium-dependent relaxant and contractile responses of isolated rabbit carotid arteries. Experimental and Toxicologic Pathology. 54(5-6). 499–504. 1 indexed citations

Schlott, Bernhard, Jens Wöhnert, Manfred Hartmann, et al.. (2002). Interaction of Kazal-type Inhibitor Domains with Serine Proteinases: Biochemical and Structural Studies. Journal of Molecular Biology. 318(2). 533–546. 51 indexed citations

Schlott, Bernhard, et al.. (2002). Fusion Proteins with Anticoagulant and Fibrinolytic Properties: Functional Studies and Structural Considerations. Molecular Pharmacology. 62(2). 203–209. 18 indexed citations

Glusa, Erika, et al.. (1998). Inhibition of thrombin-induced contractile responses by protein kinase inhibitors in porcine pulmonary arteries. Experimental and Toxicologic Pathology. 50(4-6). 497–500. 7 indexed citations

Kaiser, Brigitte, Erika Glusa, Debra A. Hoppensteadt, et al.. (1998). A supersulfated low-molecular-weight heparin (IK-SSH) increases plasma levels of free and total tissue factor pathway inhibitor after intravenous and subcutaneous administration in humans. Blood Coagulation & Fibrinolysis. 9(6). 517–524. 7 indexed citations

10.

Glusa, Erika, T Gräser, Shawn Wagner, & M. Öettel. (1997). Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins. Maturitas. 28(2). 181–191. 40 indexed citations

11.

Bretschneider, Ellen, et al.. (1997). THROMBIN BUT NOT THROMBIN RECEPTOR ACTIVATING PEPTIDE IS MITOGENIC FOR CORONARY ARTERY SMOOTH MUSCLE CELLS. Thrombosis Research. 87(5). 493–497. 7 indexed citations

12.

Schenk, Joachim, et al.. (1996). A Recombinant Hirudin (IK-HIR02) in Healthy Volunteers. Pathophysiology of Haemostasis and Thrombosis. 26(4). 187–194. 7 indexed citations

13.

Schenk, Joachim, et al.. (1996). A Recombinant Hirudin (IK-HIR02) in Healthy Volunteers. Pathophysiology of Haemostasis and Thrombosis. 26(3). 140–149. 10 indexed citations

14.

Glusa, Erika, et al.. (1996). Relaxant and Contractile Responses of Porcine Pulmonary Arteries to Thrombin and Thrombin Receptor Activating Peptides. Seminars in Thrombosis and Hemostasis. 22(3). 261–265. 17 indexed citations

15.

Bretschneider, Ellen, Erika Glusa, & Karsten Schrör. (1994). ADP-, PAF- and adrenaline-induced platelet aggregation and thromboxane formation are not affected by a thromboxane receptor antagonist at physiological external Ca++ concentrations. Thrombosis Research. 75(3). 233–242. 24 indexed citations

16.

Glusa, Erika, et al.. (1991). Endothelium-dependent relaxant effect of thrombocytin, a serine proteinase from Bothrops atrox snake venom, on isolated pig coronary arteries. Toxicon. 29(6). 725–732. 8 indexed citations

17.

Glusa, Erika & F Markwárdt. (1990). Platelet Functions in Recombinant Hirudin-Anticoagulated Blood. Pathophysiology of Haemostasis and Thrombosis. 20(2). 112–118. 33 indexed citations

18.

Markwárdt, F, et al.. (1990). Pharmacological modification of mechanical and electrical responses of frog heart to thrombin. Naunyn-Schmiedeberg s Archives of Pharmacology. 341(4). 341–346. 8 indexed citations

19.

Glusa, Erika. (1988). Thrombin induces endothelium-dependent relaxation of pig coronary arteries.. PubMed. 115(1-2). 101–5. 3 indexed citations

20.

Glusa, Erika. (1979). [Inhibition of blood platelet function].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 34(1). 17–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact